hesperetin has been researched along with Myocardial Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, L; Han, X; Jing, X; Li, J; Liu, M; Liu, P; Xue, Y; Zhang, M; Zhang, Y | 1 |
| Aromaa, A; Hakulinen, T; Heliövaara, M; Järvinen, R; Knekt, P; Kumpulainen, J; Reunanen, A; Rissanen, H | 1 |
2 other study(ies) available for hesperetin and Myocardial Ischemia
| Article | Year |
|---|---|
Hesperetin modulates the Sirt1/Nrf2 signaling pathway in counteracting myocardial ischemia through suppression of oxidative stress, inflammation, and apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Dose-Response Relationship, Drug; Electrocardiography; Heart Function Tests; Hesperidin; Inflammation; Male; Mice; Myocardial Ischemia; Myocardium; NF-E2-Related Factor 2; Oxidative Stress; Signal Transduction; Sirtuin 1; Vasodilator Agents; Verapamil | 2021 |
Flavonoid intake and risk of chronic diseases.
Topics: Adult; Arthritis, Rheumatoid; Asthma; Cataract; Cerebrovascular Disorders; Chronic Disease; Diabetes Mellitus, Type 2; Diet; Female; Flavanones; Flavonoids; Hesperidin; Humans; Kaempferols; Lung Neoplasms; Male; Middle Aged; Mortality; Myocardial Ischemia; Neoplasms; Prostatic Neoplasms; Quercetin; Risk; Risk Factors; Surveys and Questionnaires | 2002 |